Systematic Literature Review of the Epidemiological Characteristics of Pneumococcal Disease Caused by the Additional Serotypes Covered by the 20-Valent Pneumococcal Conjugate Vaccine

The 20-valent pneumococcal conjugate vaccine (PCV20): expected added value

(2022) Esther Janssens et al.   ACTA CLINICA BELGICA

Distribution of Serotypes Causing Invasive Pneumococcal Disease in Children From High-Income Countries and the Impact of Pediatric Pneumococcal Vaccination

(2022) Lindsay R Grant et al.   CLINICAL INFECTIOUS DISEASES

Streptococcus pneumoniae serotype 15B polysaccharide conjugate elicits a cross-functional immune response against serotype 15C but not 15A

(2022) Li Hao et al.   VACCINE

Effectiveness of the seven- and thirteen valent pneumococcal conjugate vaccines against vaccine-serotype otitis media

(2021) Ron Dagan et al.   CLINICAL INFECTIOUS DISEASES

Serotype Distribution of Remaining Pneumococcal Meningitis in the Mature PCV10/13 Period: Findings from the PSERENADE Project

(2021) Maria Garcia Quesada et al.   Microorganisms

Characterization of Streptococcus pneumoniae detected in clinical respiratory tract samples in southern Sweden 2 to 4 years after introduction of PCV13

(2021) Fabian Uddén et al.   JOURNAL OF INFECTION

Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants in the United States

(2021) Shelly Senders et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

1181. Serotype Distribution by Age of Remaining Invasive Pneumococcal Disease After Long-Term PCV10/13 Use: The PSERENADE Project

(2021) Maria Garcia Quesada et al.   Open Forum Infectious Diseases

Characteristics of invasive pneumococcal disease (IPD) caused by emerging serotypes after the introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) in England; prospective observational cohort study, 2014-18

(2020) Zahin Amin-Chowdhury et al.   CLINICAL INFECTIOUS DISEASES

Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age

(2020) Donald Hurley et al.   CLINICAL INFECTIOUS DISEASES

Streptococcus pneumoniae serotype distribution and antimicrobial nonsusceptibility trends among adults with pneumonia in the United States, 2009‒2017

(2020) Jose A. Suaya et al.   JOURNAL OF INFECTION

Direct effects of pneumococcal conjugate vaccines among children in Latin America and the Caribbean

(2020) Cynthia G Whitney et al.   LANCET INFECTIOUS DISEASES

Making sense of differences in pneumococcal serotype replacement

(2019) Joseph A Lewnard et al.   LANCET INFECTIOUS DISEASES

Adult vaccination for pneumococcal disease: a comparison of the national guidelines in Europe

(2019) C. Bonnave et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Increase of serotype 8, ST53 clone, as the prevalent strain of Streptococcus pneumoniae causing invasive disease in Madrid, Spain (2012–2015)

(2019) Juan Carlos Sanz et al.   ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA

Indirect effects of Paediatric Conjugate Vaccines on Invasive Pneumococcal Disease in Older Adults

(2019) Pilar Ciruela et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Factors Associated With Severe Nonmeningitis Invasive Pneumococcal Disease in Adults in France

(2019) Kostas Danis et al.   Open Forum Infectious Diseases

Pneumococcal conjugate vaccines in different settings

(2019) William P Hausdorff   LANCET INFECTIOUS DISEASES

Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study

(2018) Shamez N Ladhani et al.   LANCET INFECTIOUS DISEASES

Epidemiology of Otitis Media with Otorrhea Among Bangladeshi Children

(2018) Hakka Naziat et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Host–pathogen interactions and prognosis of critically ill immunocompetent patients with pneumococcal pneumonia: the nationwide prospective observational STREPTOGENE study

(2018) Jean-Pierre Bedos et al.   INTENSIVE CARE MEDICINE

Serotype distribution and antibiotic susceptibility of Streptococcus pneumoniae strains in the south of Tunisia: A five-year study (2012–2016) of pediatric and adult populations

(2017) Sonia Ktari et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Serotype distribution, antimicrobial resistance and prevalence of pilus islets in pneumococci following the use of conjugate vaccines

(2017) Mitsuyo Kawaguchiya et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis

(2017) Evelyn Balsells et al.   PLoS One

Rise of multidrug-resistant non-vaccine serotype 15A Streptococcus pneumoniae in the United Kingdom, 2001 to 2014

(2016) Carmen Sheppard et al.   Eurosurveillance

Early Changes in the Serotype Distribution of Invasive Pneumococcal Isolates from Children after the Introduction of Extended-valent Pneumococcal Conjugate Vaccines in Korea, 2011-2013

(2016) Eun Young Cho et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Invasive Streptococcus pneumoniae in Canada, 2011–2014: Characterization of new candidate 15-valent pneumococcal conjugate vaccine serotypes 22F and 33F

(2016) Alyssa R. Golden et al.   VACCINE

Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012–2014

(2016) Satoshi Nakano et al.   VACCINE

Invasive pneumococcal disease: Clinical outcomes and patient characteristics 2–6 years after introduction of 7-valent pneumococcal conjugate vaccine compared to the pre-vaccine period, the Netherlands

(2016) Gertjan H.J. Wagenvoort et al.   VACCINE

Noninvasive Streptococcus pneumoniae Serotypes Recovered from Hospitalized Adult Patients in the United States in 2009 to 2012

(2015) Rodrigo E. Mendes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Streptococcus pneumoniae: distribución de serotipos, sensibilidad antibiótica, factores de riesgo y mortalidad en Galicia en un periodo de 2 años

(2015) Susana Méndez-Lage et al.   ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA

Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance

(2015) Matthew R Moore et al.   LANCET INFECTIOUS DISEASES

Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults

(2015) Marc J.M. Bonten et al.   NEW ENGLAND JOURNAL OF MEDICINE

Invasive disease potential of pneumococci before and after the 13-valent pneumococcal conjugate vaccine implementation in children

(2015) Emmanuelle Varon et al.   VACCINE

Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995–2011

(2013) Wallis Rudnick et al.   VACCINE

Variations in serotypes and susceptibility of adult non-invasive Streptococcus pneumoniae isolates between the periods before (May 2000–May 2001) and 10 years after (May 2010–May 2011) introduction of conjugate vaccines for child immunisation in Spain

(2012) Asunción Fenoll et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Effect of Serotype on Focus and Mortality of Invasive Pneumococcal Disease: Coverage of Different Vaccines and Insight into Non-Vaccine Serotypes

(2012) Albert Jan van Hoek et al.   PLoS One

Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study

(2011) Elizabeth Miller et al.   LANCET INFECTIOUS DISEASES

Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease

(2010) Inci Yildirim et al.   VACCINE